arrow
P

Pierre Fontana

University of Geneva
H指数:46
被引数:7,413

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A comprehensive multicenter study assessing the impact of abelacimab, asundexian and milvexian on coagulation assays

一项综合多中心研究评估阿贝拉卡姆单抗、阿孙德西安和米尔韦西安对凝血测定的影响

2026-05-280
OAAI
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban

在接受阿哌沙班或利伐沙班治疗的住院患者中使用基于生理的药代动力学模型的虚拟双胞胎方法

2025-03-010
OA
Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis

抗凝血因子XI(a)患者在出血和侵入性操作中的管理:法国围手术期止血工作组及法国血栓与止血学会的建议

2025-03-010
OAAI
Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network

围术期静脉血栓栓塞症的预防:法国围术期止血工作组(GIHP)2024年指南,由其与法国麻醉与重症医学学会(SFAR)、法国血栓与止血学会(SFTH)和法国血管医学学会(SFMV)合作制定,并得到法国消化外科学会(SFCD)、法国药理学与治疗学学会(SFPT)以及INNOVTE(静脉血栓栓塞症研究网络)的支持。

2024-10-220
OAAI
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology
2023-09-016
OAAI
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe
2023-02-182
PRE
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group
2022-10-219
PRE
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study

在临床实践中测量利伐沙班、阿哌沙班和依多沙班药物浓度的凝血酶原诱导凝血时间: 一项横断面研究

2022-07-111
OAAI